Wednesday, August 24, 2016

BRIEF-Biopharmx enrolls first subject in OPAL Phase 2B clinical trial

* Biopharmx enrolls first subject in OPAL Phase 2B clinical

trial of bpx-01 topical minocycline for treatment of acne

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)